EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of high-performing antibodies for Superoxide dismutase [Cu-Zn] 1 (SOD1) for use in Western blot, immunoprecipitation, and immunofluorescence

Riham Ayoubi, Walaa Alshafie, Zhipeng You, Kathleen Southern iD, Peter S McPherson, Carl Laflamme iD

F1000Research · 31.08.2023 · 12 · 391

DOI: 10.12688/f1000research.132952.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 31.08.2023. Verfasst von Riham Ayoubi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H…. Hauptthemen laut MEDLINE: Superoxide Dismutase-1, Fluorescent Antibody Technique, Immunoprecipitation, Blotting, Western. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Ontario Genomics, ALS Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Superoxide dismutase [Cu-Zn] 1 (SOD1), is an antioxidant enzyme encoded by the gene SOD1 , responsible for regulating oxidative stress levels by sequestering free radicals. Identified as the first gene with mutations in Amyotrophic lateral sclerosis (ALS), SOD1 is a determinant for studying diseases of aging and neurodegeneration. With guidance on well-characterized anti-SOD1 antibodies, the reproducibility of SOD1 research would be enhanced. In this study, we characterized eleven SOD1 commercial antibodies for Western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. We identified many high-performing antibodies and encourage readers to use this report as a guide to select the most appropriate antibody for their specific needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Superoxide Dismutase-1Fluorescent Antibody TechniqueImmunoprecipitationBlotting, WesternAntibodiesHumansAnimalsMice

Stichwörter der Autor:innen

SOD1Superoxide dismutase 1Superoxide dismutase [Cu-Zn]Uniprot ID P00441Western blotantibody characterizationantibody validationimmunofluorescenceimmunoprecipitation

Substanzen

Superoxide Dismutase-1AntibodiesSOD1 protein, human

Autor:innen und Institutionen

  • Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H34 2B4, Canada.
  • The Neuro's Early Drug Discovery Unit (EDDU), Structural Genomics Consortium, McGill University, Montreal, Québec, H3A 2B4, Canada.

ORCID-Profile: Kathleen Southern, Carl Laflamme

Förderung

  • CIHR
  • Ontario Genomics
  • ALS Association
  • Genome Canada
  • ALS Society of Canada
  • Motor Neurone Disease Association
  • Mitacs
  • Canadian Institutes of Health Research Foundation

Zitieren

APA

Ayoubi, R., Alshafie, W., You, Z., Southern, K., McPherson, P. S., & Laflamme, C. (2023). Identification of high-performing antibodies for Superoxide dismutase [Cu-Zn] 1 (SOD1) for use in Western blot, immunoprecipitation, and immunofluorescence. F1000Research, 12, 391. https://doi.org/10.12688/f1000research.132952.2

Vancouver

Ayoubi R, Alshafie W, You Z, Southern K, McPherson PS, Laflamme C. Identification of high-performing antibodies for Superoxide dismutase [Cu-Zn] 1 (SOD1) for use in Western blot, immunoprecipitation, and immunofluorescence. F1000Research. 2023;12:391. doi:10.12688/f1000research.132952.2

BibTeX
@article{Ayoubi2023,
  author = {Ayoubi, Riham and Alshafie, Walaa and You, Zhipeng and Southern, Kathleen and McPherson, Peter S and Laflamme, Carl},
  title = {Identification of high-performing antibodies for Superoxide dismutase [Cu-Zn] 1 (SOD1) for use in Western blot, immunoprecipitation, and immunofluorescence},
  journal = {F1000Research},
  year = {2023},
  volume = {12},
  pages = {391},
  doi = {10.12688/f1000research.132952.2}
}
Kostenlos starten →